U. Abshagen

1.4k total citations
68 papers, 982 citations indexed

About

U. Abshagen is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Molecular Biology. According to data from OpenAlex, U. Abshagen has authored 68 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Pharmacology and 14 papers in Molecular Biology. Recurrent topics in U. Abshagen's work include Pharmacogenetics and Drug Metabolism (13 papers), Analytical Methods in Pharmaceuticals (13 papers) and Hormonal Regulation and Hypertension (12 papers). U. Abshagen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Analytical Methods in Pharmaceuticals (13 papers) and Hormonal Regulation and Hypertension (12 papers). U. Abshagen collaborates with scholars based in Germany and United States. U. Abshagen's co-authors include N. Rietbrock, B. Kaufmann, G Betzien, R. Endele, K. von Bergmann, G. Neugebauer, K. Koch, J. Kuhlmann, E von Möllendorff and Pernilla Lång and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Cardiology and Biochemical Pharmacology.

In The Last Decade

U. Abshagen

67 papers receiving 854 citations

Peers

U. Abshagen

CCM

EDM

PHARM

N. Rietbrock Germany

J H Silas United Kingdom

G. Neugebauer Germany

HL Elliott United Kingdom

C. H. Kleinbloesem Switzerland

C. Harvengt Belgium

Robert E. Rangno Canada

Kenneth L. Duchin United States

A. Sioufi Switzerland

Roger K. Ferguson United States

N. Rietbrock Germany

U. Abshagen

196 ×0.8

CCM

231 ×1.1

EDM

218 ×1.1

PHARM

361 ×2.2

91 ×0.6

Citations per year, relative to U. Abshagen U. Abshagen (= 1×) peers N. Rietbrock

Countries citing papers authored by U. Abshagen

Since Specialization

Citations

This map shows the geographic impact of U. Abshagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Abshagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Abshagen more than expected).

Fields of papers citing papers by U. Abshagen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Abshagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Abshagen. The network helps show where U. Abshagen may publish in the future.

Co-authorship network of co-authors of U. Abshagen

This figure shows the co-authorship network connecting the top 25 collaborators of U. Abshagen. A scholar is included among the top collaborators of U. Abshagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Abshagen. U. Abshagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abshagen, U.. (1992). Pharmacokinetics of isosorbide mononitrate. The American Journal of Cardiology. 70(17). G61–G66. 33 indexed citations

Barrett, Richard J., et al.. (1988). Isosorbide‐5‐mononitrate. Cardiovascular Drug Reviews. 6(1). 54–70. 1 indexed citations

Abshagen, U.. (1987). A New Molecule with Vasodilating and β-Adrenoceptor Blocking Properties. Journal of Cardiovascular Pharmacology. 10. S23–S32. 6 indexed citations

Abshagen, U.. (1987). A New Molecule with Vasodilating and p-Adrenoceptor Blocking Properties. Journal of Cardiovascular Pharmacology. 10(Supplement). S23–S32. 1 indexed citations

Abshagen, U. & E von Möllendorff. (1986). Haemodynamic Abnormalities in Hypertensive Patients: A Review of the Influence of Vasodilating Drugs. Journal of International Medical Research. 14(6). 289–298. 2 indexed citations

Grützmacher, P., E. Scheuermann, W Siede, et al.. (1986). Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: Pharmacokinetics and effects. Journal of Molecular Medicine. 64(19). 910–916. 10 indexed citations

Abshagen, U., G Betzien, R. Endele, B. Kaufmann, & G. Neugebauer. (1985). Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration. European Journal of Clinical Pharmacology. 27(6). 637–644. 25 indexed citations

Abshagen, U., W. Bablok, K. Koch, et al.. (1979). Disposition pharmacokinetics of bezafibrate in man. European Journal of Clinical Pharmacology. 16(1). 31–38. 50 indexed citations

Abshagen, U.. (1978). [Influence of disease on the kinetics of drugs in the organism].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(6). 340–8. 2 indexed citations

10.

Abshagen, U., et al.. (1978). Non-interaction of spironolactone medication and cortisol metabolism in man. Journal of Molecular Medicine. 56(3). 135–138. 6 indexed citations

11.

Abshagen, U., et al.. (1977). Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man. Naunyn-Schmiedeberg s Archives of Pharmacology. 300(3). 281–287. 20 indexed citations

12.

Abshagen, U., et al.. (1977). Increased Plasma 11-Deoxycorticosterone During Spironolactone Medication. The Journal of Clinical Endocrinology & Metabolism. 44(6). 1190–1193. 19 indexed citations

13.

Rietbrock, N., et al.. (1975). Disposition of β-methyldigoxin in man. European Journal of Clinical Pharmacology. 9(2-3). 105–114. 15 indexed citations

14.

Abshagen, U., et al.. (1974). Formation and disposition of bis- and monoglycosides after administration of3H-4?-methyldigoxin to man. European Journal of Clinical Pharmacology. 7(3). 177–181. 5 indexed citations

15.

Abshagen, U., et al.. (1972). Pharmacokinetic behaviour of 4?-methyldigoxin in man. Naunyn-Schmiedeberg s Archives of Pharmacology. 273(1-2). 172–174. 13 indexed citations

16.

Abshagen, U., K. von Bergmann, & N. Rietbrock. (1972). Evaluation of the enterohepatic circulation after 3H-digoxin administration in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 275(1). 1–10. 15 indexed citations

17.

Rietbrock, N. & U. Abshagen. (1972). A method for investigation of enterohepatic circulation. Naunyn-Schmiedeberg s Archives of Pharmacology. 274(2). 208–210. 4 indexed citations

18.

Rietbrock, N., U. Abshagen, K. von Bergmann, & H. Kewitz. (1972). Pharmacokinetics of digoxin and its 4?-acetyl-and methylderivates in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 274(2). 171–181. 23 indexed citations

19.

Abshagen, U. & N. Rietbrock. (1970). Zum Mechanismus der 2-Propanoloxydation: Interferenzversuche mit niederen aliphatischen Alkoholen in vivo und an der isoliert perfundierten Rattenleber. Naunyn-Schmiedeberg s Archives of Pharmacology. 265(5). 411–424. 4 indexed citations

20.

Abshagen, U. & N. Rietbrock. (1970). Zum Mechanismus der 2-Propanoloxydation. Naunyn-Schmiedeberg s Archives of Pharmacology. 265(5). 411–424. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact